BRATTON DOUGLAS K 13D and 13G filings for Aquestive Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-13 11:38 am Sale | 2024-12-31 | 13G | Aquestive Therapeutics, Inc. AQST | BRATTON DOUGLAS K | 10,077,434 11.100% | -40,000 (-0.40%) | Filing |
| 2022-02-11 4:03 pm Sale | 2021-12-31 | 13G | Aquestive Therapeutics, Inc. AQST | BRATTON DOUGLAS K | 10,117,434 25.200% | -1,494,320 (-12.87%) | Filing |
| 2021-02-09 3:19 pm Purchase | 2020-12-31 | 13G | Aquestive Therapeutics, Inc. AQST | BRATTON DOUGLAS K | 11,611,754 34.500% | 26,700 (+0.23%) | Filing |